How Gilead is positioning its COVID-19 drug against newer antivirals like Paxlovid

The company has an oral version of its COVID-19 drug Veklury in a clinical trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.